Detalhe da pesquisa
1.
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants.
Cell
; 186(7): 1432-1447.e17, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001503
2.
Pharmacologic modulation of RNA splicing enhances anti-tumor immunity.
Cell
; 184(15): 4032-4047.e31, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171309
3.
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
Cell
; 183(2): 363-376.e13, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007267
4.
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction.
Cell
; 183(3): 818-834.e13, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33038342
5.
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade.
Cell
; 173(3): 624-633.e8, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29656892
6.
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors.
Nat Immunol
; 21(3): 298-308, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066953
7.
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer.
Immunity
; 56(1): 93-106.e6, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36574773
8.
Curbing Tregs' (Lack of) Enthusiasm.
Cell
; 169(6): 981-982, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28575677
9.
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.
Cell
; 170(5): 927-938.e20, 2017 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28841418
10.
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance.
Nat Immunol
; 20(11): 1555, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31551574
11.
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance.
Nat Immunol
; 20(9): 1231-1243, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31358999
12.
Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors.
Immunity
; 54(7): 1561-1577.e7, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102100
13.
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.
Cell
; 162(5): 974-86, 2015 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26317466
14.
Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.
Cell
; 156(5): 986-1001, 2014 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24581497
15.
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.
Nature
; 618(7963): 144-150, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37165196
16.
Fundamental immune-oncogenicity trade-offs define driver mutation fitness.
Nature
; 606(7912): 172-179, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545680
17.
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer.
Nature
; 606(7913): 389-395, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589842
18.
Anatomic position determines oncogenic specificity in melanoma.
Nature
; 604(7905): 354-361, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35355015
19.
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses.
Cell
; 169(2): 361, 2017 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28388418
20.
CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours.
Nature
; 591(7851): 652-658, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588426